Atox Bio
A company developing immunomodulators to treat acute inflammatory conditions
2
Funding Rounds
$33.3m
Money raised
Overview
A company developing immunomodulators to treat acute inflammatory conditions
- Website:
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Atox Bio has raised a total of $33.25m in funding over 2 rounds.
Key Insights:
- Atox Bio , December 2017: $30m
- Atox Bio Series A round: $3.25m
Atox Bio , December 2017
$30m
Atox Bio Series A round
$3.25m
Industries
Atox Bio is active in the following industries: